Patent US4801449A successfully refreshed from Google Patents.
US4801449A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for treatment of Kaposi's sarcoma
Assignee: Cypress Bioscience Inc
•
Filing: 1986-12-31
•
Granted: 1989-01-31
•
Expires: 2006-12-31
Abstract
Abstract An immunoadsorbent material for removing IgG and IgG-complexes from biological fluids is prepared by covalently binding protein A to a solid-phase silica matrix. It has been found that particularly stable, high-capacity immunoadsorbents are obtained by derivatizing the silica with amino and/or carboxyl groups, and reacting the protein A with a carbodiimide at a pH in the range from 3.5 to 4.5. Binding through free hydroxyl groups may be achieved with cyanogen halides at a pH in the range from 11.0 to 11.5. After acid washing (pH 2.0-2.5) to remove non-covalently bound protein A, the immunoadsorbent may be employed in a column for therapeutic treatment of various cancers and autoimmune disorders where IgG-complexes are implicated as suppressing factors in inhibiting a normal immune response. The column has been successfully employed in treating patients suffering from Kaposi's sarcoma.
Inventors
- 👤 Joseph P. Balint, Jr.
- 👤 Frank R. Jones
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-10 01:49
CPC Classifications
B; B01; B01J; B01J20/00; B01J20/30; B01J20/32; B01J20/3202; B01J20/3204; B01J20/02; B01J20/10; B01J20/103; B01J20/28; B01J20/28002; B01J20/28004; B01J20/3071; B01J20/3078; B01J20/3085; B01J20/3092; B01J20/3214; B01J20/3217; B01J20/3219; B01J20/3231; B01J20/3242; B01J20/3244; B01J20/3246; B01J20/3257; B01J20/3263; B01J20/3268; B01J20/3272; B01J20/3274; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/551; G01N33/552; A; A61; A61M; A61M1/00; A61M1/36; A61M1/3679; B01J2220/00; B01J2220/50; B01J2220/58; B01J2220/62
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
39 words
A method for treating a patient suffering from Kaposi's sarcoma, said method comprising extracorporeally contacting the patient's plasma with an immunoadsorbent material capable of binding immune complexes in order to effect removal of immune complexes from the patient's blood.
Claim 2
Independent Claim
39 words
A method for treating a patient suffering from Kaposi's sarcoma, said method comprising extracorporeally contacting the patient's plasma with an immunoadsorbent material capable of binding immune complexes in order to effect removal of immune complexes from the patient's blood.
Claim 3
Dependent Claim
18 words
A method as in claim 1, wherein the immunoadsorbent is protein A covalently bound to an inert matrix.
Claim 4
Dependent Claim
12 words
A method as in claim 2, wherein the inert matrix is silica.
Claim 5
Independent Claim
55 words
A method for treating a patient suffering from Kaposi's sacroma, said method comprising the steps: (a) drawing blood from the patient; (b) contacting plasma from the patient's blood with an immunoadsorbent material capable of binding immune complexes in order to effect removal of said immune complexes; and (c) reinfusing the treated blood into the patient.
Claim 6
Independent Claim
55 words
A method for treating a patient suffering from Kaposi's sacroma, said method comprising the steps: (a) drawing blood from the patient; (b) contacting plasma from the patient's blood with an immunoadsorbent material capable of binding immune complexes in order to effect removal of said immune complexes; and (c) reinfusing the treated blood into the patient.
Claim 7
Dependent Claim
27 words
A method as in claim 4, wherein a continuous flow of blood is drawn from the patient and treated blood is returned while additional blood is drawn.
Claim 8
Dependent Claim
38 words
A method as in claim 5, wherein the flow of blood is continuously separated into cellular components and plasma, the plasma contacted with a protein A immunoadsorbent, and the cellular components and treated plasma reinfused into the patient.
Claim 9
Dependent Claim
15 words
A method as in claim 4, wherein the steps (a) through (c) are repeated periodically.
Claim 10
Independent Claim
44 words
A method for treating a patient suffering from Kaposi's sarcoma, said method comprising: (a) recovering plasma from the patient; (b) contacting the plasma with an immunoadsorbent material comprising protein A covalently attached to an inert matrix; and (c) returning the plasma to the patient.
Claim 11
Independent Claim
44 words
A method for treating a patient suffering from Kaposi's sarcoma, said method comprising: (a) recovering plasma from the patient; (b) contacting the plasma with an immunoadsorbent material comprising protein A covalently attached to an inert matrix; and (c) returning the plasma to the patient.
Claim 12
Dependent Claim
14 words
A method as in claim 8, wherein steps (a) through (c) are repeated periodically.
Claim 13
Dependent Claim
37 words
A method as in claim 9, wherein the plasma is recovered by drawing a continuous flow of blood from the patient, separating the blood into plasma and cellular components, and reinfusing the cellular components to the patient.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-01-31 | 1992-08-01 | 1993-01-31 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-01-31 | 1996-08-01 | 1997-01-31 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-01-31 | 2000-08-01 | 2001-01-31 | $7700.00 | Window Closed / Lapsed |